Every year the FTC brings hundreds of cases against individuals and companies for violating consumer protection and competition laws that the agency enforces. These cases can involve fraud, scams, identity theft, false advertising, privacy violations, anti-competitive behavior and more. The Legal Library has detailed information about cases we have brought in federal court or through our internal administrative process, called an adjudicative proceeding.
Displaying 2061 - 2080 of 5960
Bedford Laboratories/Hikma Pharmaceuticals, In the Matter of
Generic drug marketer Hikma Pharmaceuticals PLC agreed to divest its rights and interests in five generic injectable pharmaceuticals to settle charges that its $5 million acquisition of the rights to various drug products and related assets from Ben Venue Laboratories, Inc. would likely be anticompetitive. According to the complaint, without a remedy, Hikma’s purchase of certain generic injectables would likely harm future competition in the U.S. markets for (1) Acyclovir sodium injection: an antiviral drug used to treat chicken pox, herpes, and other related infections, (2) Diltiazem hydrochloride injection: a calcium channel blocker and antihypertensive used to treat hypertension, angina, and arrhythmias, (3) Famotidine injection: a treatment for ulcers and gastroesophageal reflux disease, (4) Prochlorperazine edisylate injection: an antipsychotic drug used to treat schizophrenia and nausea, and (5) Valproate sodium injection: a treatment for epilepsy, seizures, bipolar disorder, anxiety, and migraine headaches. Hikma is required to divest the five generic injectable drug assets to Amphastar Pharmaceuticals, Inc., a California-based specialty pharmaceutical company that sells generic injectable and inhalation products.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
151 0044
Dissenting Statement of Commissioner Maureen K. Ohlhausen In the Matter of Endo Pharmaceuticals Inc.
Date
Matter Number
1410004
Oracle Corporation, In the Matter of
Type of Action
Administrative
Last Updated
FTC Matter/File Number
132 3115
C4571
Rangers Renal Holding, LP; US Renal Care, Inc.; Dialysis Parent, LLC and Dialysis HoldCo, LLC, In the Matter of
To settle charges that its acquisition of DSI Renal would substantially lessen competition for outpatient dialysis services in Laredo, Texas, U.S. Renal agreed to divest three clinics to Satellite Healthcare, Inc.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
151 0215
Sitesearch Corporation, Doing Business As LeapLab
Type of Action
Federal
Last Updated
FTC Matter/File Number
142 3192
X150060
Machinima, Inc., In the Matter of
Type of Action
Administrative
Last Updated
FTC Matter/File Number
142 3090
Ideal Financial Solutions, Inc., et al.
Type of Action
Federal
Last Updated
FTC Matter/File Number
1123211
X130044
Nature Works Best Cancer Clinic
Date
By
Mary K. Engle, Associate Director
File
Text of the Letter
(166.38 KB)
Letter From Chairwoman Edith Ramirez To Vĕra Jourová, Commissioner for Justice, Consumers and Gender Equality of the European Commission, Describing Federal Trade Commission Enforcement of the New EU-U.S. Privacy Shield Framework
Date
By
Edith Ramirez, Ex Comisionada
Matter Number
P859900
The Robert Larson Automotive Group, Inc., Also doing Business as Larson Volkswagen and Audi Tacoma
Date
Matter Number
162 3006
Carrot Neurotechnology, Inc., In the Matter of (UltimEyes)
Type of Action
Administrative
Last Updated
FTC Matter/File Number
142 3132
Displaying 2061 - 2080 of 5960